Literature DB >> 11494363

In vitro generation and transplantation of precursor-derived human dopamine neurons.

R Sánchez-Pernaute1, L Studer, K S Bankiewicz, E O Major, R D McKay.   

Abstract

The use of in vitro expanded human CNS precursors has the potential to overcome some of the ethical, logistic and technical problems of fetal tissue transplantation in Parkinson disease. Cultured rat mesencephalic precursors proliferate in response to bFGF and upon mitogen withdrawal, differentiate into functional dopamine neurons that alleviate motor symptoms in Parkinsonian rats (Studer et al. [1998] Nat. Neurosci. 1:290-295). The successful clinical application of CNS precursor technology in Parkinson disease will depend on the efficient in vitro generation of human dopaminergic neurons. We demonstrate that human dopamine neurons can be generated from both midbrain and cortical precursors. Transplantation of midbrain precursor-derived dopamine neurons into Parkinsonian rats resulted in grafts rich in tyrosine hydroxylase positive neurons 6 weeks after transplantation. No surviving tyrosine hydroxylase positive neurons could be detected when dopamine neurons derived from cortical precursors were grafted. Our data demonstrate in vitro derivation of human dopamine neurons from expanded CNS precursors and encourage further studies that systematically address in vivo function and clinical potential. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494363     DOI: 10.1002/jnr.1152

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  27 in total

1.  Generation of functional human serotonergic neurons from fibroblasts.

Authors:  K C Vadodaria; J Mertens; A Paquola; C Bardy; X Li; R Jappelli; L Fung; M C Marchetto; M Hamm; M Gorris; P Koch; F H Gage
Journal:  Mol Psychiatry       Date:  2015-10-27       Impact factor: 15.992

2.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

3.  The promise of stem cells in Parkinson disease.

Authors:  J William Langston
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

4.  Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease.

Authors:  Rosario Sanchez-Pernaute; Hyojin Lee; Michaela Patterson; Casper Reske-Nielsen; Takahito Yoshizaki; Kai C Sonntag; Lorenz Studer; Ole Isacson
Journal:  Brain       Date:  2008-07-22       Impact factor: 13.501

5.  Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson disease.

Authors:  Jose A Rodríguez-Gómez; Jian-Qiang Lu; Iván Velasco; Seth Rivera; Sami S Zoghbi; Jeih-San Liow; John L Musachio; Frederick T Chin; Hiroshi Toyama; Jurgen Seidel; Michael V Green; Panayotis K Thanos; Masanori Ichise; Victor W Pike; Robert B Innis; Ron D G McKay
Journal:  Stem Cells       Date:  2006-12-14       Impact factor: 6.277

Review 6.  Cell-based therapies in Parkinson's disease.

Authors:  Paul Greene
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

7.  Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient?

Authors:  Aileen J Anderson; Daniel L Haus; Mitra J Hooshmand; Harvey Perez; Christopher J Sontag; Brian J Cummings
Journal:  Regen Med       Date:  2011-05       Impact factor: 3.806

Review 8.  Current challenges for the advancement of neural stem cell biology and transplantation research.

Authors:  Kristien Reekmans; Jelle Praet; Jasmijn Daans; Veerle Reumers; Patrick Pauwels; Annemie Van der Linden; Zwi N Berneman; Peter Ponsaerts
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 9.  Adult human neural stem cell therapeutics: Current developmental status and prospect.

Authors:  Hyun Nam; Kee-Hang Lee; Do-Hyun Nam; Kyeung Min Joo
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

Review 10.  Stem cells in human neurodegenerative disorders--time for clinical translation?

Authors:  Olle Lindvall; Zaal Kokaia
Journal:  J Clin Invest       Date:  2010-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.